When: Close below $134.95 on volume >10M

Then: Exit remaining position; downgrade to Underweight

HOLD

• Hold current position as portfolio ballast with 4.17% dividend yield
• Monitor 50 SMA at 140.05 as line in the sand for potential position review
• Triggers for 10-15% measured trim: sustained close below 140.05 on rising volume AND softening FCF coverage ratio
• Do not sell calls against position as capping upside in a defensive dividend payer is structurally wrong
• Keep stop wide or absent given beta of 0.36 means routine volatility should not trigger position reductions
• 50 billion in revenue, 12 billion in operating cash flow, 10x interest coverage provides balance sheet to defend dividend
• Stock down 11% over 3 years and 13% over 5 years suggests GLP-1 risk already priced in
• MACD histogram turning positive and RSI at 59 with room to run indicates constructive technical setup
• Dividend coverage at 1.00x FCF is tight but imminent cut unlikely without multi-quarter multi-signal deterioration
• Aggressive analyst's 147 and 151 scaling exits are conditional on 200 SMA reclaim which has rejected every rally since February

→ vs aggressive: 25-30% trim proposed at 143.48 with 155 call sale and 128 stop is a momentum playbook applied to a defensive name that will leak alpha; capping upside for call premium in a name that cannot reclaim 200 SMA at 147 means forfeiture of meaningful upside for rounding error premium on a 195 billion market cap position

→ vs aggressive: SELL framing as alpha-generating move is sleight of hand; 147 and 151 scaling exits are conditional on technical cooperation that has failed for six months; if levels don't get reclaimed, position slides toward 138, 135, and 128 with capped upside from sold calls

→ vs aggressive: GLP-1 risk has already had multi-year head start being priced in given 11% underperformance over 3 years and 13% over 5 years; quiet consolidation near 143 with positive MACD histogram and constructive RSI suggests market has digested this risk, not that it is unpriced and accelerating

→ vs neutral: Add below 135 recommendation is premature; 134.95 retest is not an entry signal given technicals showing distribution into resistance and tight dividend coverage; this is the textbook falling knife the aggressive analyst correctly warned about

BUY (modest trim - reduce to 85-90% of benchmark weight from full position)

• 6.62M shares on bounce vs 7-9M norm is distribution signature, not noise
• 200 SMA at $147.09 has been hard ceiling since February
• Beta of 0.36 makes HOLD the low-risk position, not high-risk—the aggressive conflates drawdown potential with portfolio risk
• GLP-1 partially priced in for 6-12 months but structural multi-year headwind; stock down 11% over 3 years and 13% over 5 years during GLP-1 expansion
• 1.00x FCF coverage with no buffer means dividend structurally fragile but unlikely cut in next 6 months
• Trim 10-15% at current $142-$144 levels, not waiting for $147 or $151 fills which may never come
• Use 50 SMA at $140 as active management line—$128 stop too tight, no stop too loose
• No upside calls at $155—caps right tail of return distribution for negligible premium on $196B market cap name
• Risk management IS about pre-emptive action, not waiting for confirmation
• If PEP reclaims 200 SMA at $147 on volume with constructive RSI, consider adding back toward benchmark weight
• Macro: higher for longer rates at 85% probability caps multiple expansion; low recession odds at 8% eliminates defensive flight-to-safety bid
• Reassess at Q3 earnings

→ vs aggressive: HOLD is not the high-risk position—beta of 0.36 makes it the low-risk position by construction; conflating drawdown potential with portfolio risk is a category error

→ vs aggressive: GLP-1 is priced in—stock down 11% over 3 years and 13% over 5 years during GLP-1 expansion proves the market has been digesting this risk

→ vs aggressive: Selling upside calls at $155 is structurally wrong—on $196B market cap the premium is a rounding error while asymmetric risk forfeits all upside above $155 if 200 SMA is reclaimed

→ vs conservative: Risk management IS about pre-emptive action; waiting for 50 SMA break with volume means executing at $138 or $135, not $143—selling into weakness

→ vs conservative: No stop is wrong—stops are about thesis invalidation, not volatility; if PEP closes below $134 on volume with deteriorating FCF, the entire defensive compounder thesis breaks

→ vs conservative: GLP-1 is not fully priced in—it is priced in cyclically but remains a real structural headwind warranting modest underweight, not full benchmark weight